The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...
Time on MSN8d
Why Johnson & Johnson’s CEO Welcomes ScrutinyDuato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results